Adial Pharmaceuticals(ADIL),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community - To The Moon

At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.

Close

ADIL Adial Pharmaceuticals

Pre-Market Trading 01-06 06:54:14 EST

1.09

+0.03

+2.78%

High1.10	Low1.05	Vol75.97K
Open1.07	D1 Closing1.06	Amplitude4.71%
Mkt Cap6.98M	Tradable Cap6.49M	Total Shares6.41M
T/O81.08K	T/O Rate1.28%	Tradable Shares5.95M
P/B--	ROE--	EPS0.00
52wk High--	52wk Low--	P/E--
Dividend--	Div.Yield--	ROA--

{"stockData":{"symbol":"ADIL","market":"US","secType":"STK","nameCN":"Adial Pharmaceuticals","latestPrice":1.09,"timestamp":1735938000000,"preClose":1.0605,"halted":0,"volume":75974,"delay":0,"floatShares":5954220,"shares":6405781,"eps":-3.405384,"marketStatus":"Pre-Market Trading","change":0.0295,"latestTime":"01-06 06:54:14 EST","open":1.07,"high":1.1,"low":1.05,"amount":81078.267606,"amplitude":0.047148,"askPrice":1.19,"askSize":100,"bidPrice":0.9805,"bidSize":200,"shortable":3,"etf":0,"ttmEps":-3.405384,"tradingStatus":1,"nextMarketStatus":{"tag":"Open","tradingStatus":2,"beginTime":1736173800000},"marketStatusCode":1,"adr":0,"adrRate":0,"listingDate":1532664000000,"exchange":"NASDAQ","adjPreClose":1.09,"postHourTrading":{"tag":"盘后","latestPrice":1.09,"preClose":1.09,"latestTime":"18:19 EST","volume":12,"amount":12.71,"timestamp":1735946381123},"volumeRatio":0.67416926667279,"impliedVol":3.592,"impliedVolPercentile":0},"requestUrl":"/m/hq/s/ADIL","defaultTab":"news","newsList":[{"id":"2493347737","title":"Adial Pharmaceuticals Files Preliminary Prospectus for Secondary Stock Sale","url":"https://stock-news.laohu8.com/highlight/detail?id=2493347737","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2493347737?lang=en_us&edition=fundamental","pubTime":"2024-12-21 06:00","pubTimestamp":1734732009,"startTime":"0","endTime":"0","summary":"Adial Pharmaceuticals  late Friday said Alumni Capital plans to sell up to 5 million shares of its stock from time to time, including 68,807 shares it issued through a commitment agreement.The upcoming stock sale could include shares acquired by Alumni Capital through a $5 million purchase agreement disclosed late last week.The preliminary prospectus filed Friday does not require Alumni Capital to sell a particular number of shares or establish a deadline or set a price for any future stock sale, Adail Pharmaceuticals said.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4007","ADIL"],"gpt_icon":1},{"id":"2493723174","title":"BRIEF-Adial Pharmaceuticals Inc - Prospectus Relates To Resale Of Up To 5 Million Shares Offered By Alumni Capital","url":"https://stock-news.laohu8.com/highlight/detail?id=2493723174","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2493723174?lang=en_us&edition=fundamental","pubTime":"2024-12-21 05:46","pubTimestamp":1734731209,"startTime":"0","endTime":"0","summary":"BRIEF-Adial Pharmaceuticals Inc - Prospectus Relates To Resale Of Up To 5 Million Shares Offered By Alumni CapitalDec 20  - Adial Pharmaceuticals Inc ADIL.O:ADIAL PHARMACEUTICALS INC - PROSPECTUS RELATES TO RESALE OF UP TO 5 MILLION SHARES OFFERED BY ALUMNI CAPITALSource text: [ID:n0001213900-24-111171]Further company coverage: ADIL.O ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20241220:nFWN3NL0TV:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ADIL","BK4007"],"gpt_icon":0},{"id":"2493471209","title":"Adial Pharmaceuticals files to sell 5.0M shares of common stock for holders","url":"https://stock-news.laohu8.com/highlight/detail?id=2493471209","media":"TIPRANKS","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2493471209?lang=en_us&edition=fundamental","pubTime":"2024-12-21 05:20","pubTimestamp":1734729653,"startTime":"0","endTime":"0","summary":"16:15 EST Adial Pharmaceuticals (ADIL) files to sell 5.0M shares of common stock for holders Published first on TheFly – the ultimate source for re...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/adial-pharmaceuticals-files-to-sell-5-0m-shares-of-common-stock-for-holders?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/adial-pharmaceuticals-files-to-sell-5-0m-shares-of-common-stock-for-holders?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["ADIL","BK4007"],"gpt_icon":0},{"id":"2493713084","title":"Adial Pharmaceuticals Inc - Prospectus Relates to Resale of up to 5 Mln Shares Offered by Alumni Capital","url":"https://stock-news.laohu8.com/highlight/detail?id=2493713084","media":"THOMSON REUTERS","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2493713084?lang=en_us&edition=fundamental","pubTime":"2024-12-21 05:07","pubTimestamp":1734728859,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20241220:nFWN3NL0TV:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["ADIL","BK4007"],"gpt_icon":0},{"id":"2492634611","title":"Adial Pharmaceuticals’ New Purchase Agreement with Alumni Capital","url":"https://stock-news.laohu8.com/highlight/detail?id=2492634611","media":"TIPRANKS","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2492634611?lang=en_us&edition=fundamental","pubTime":"2024-12-19 06:34","pubTimestamp":1734561263,"startTime":"0","endTime":"0","summary":"An update from Adial Pharmaceuticals ( ($ADIL) ) is now available. Adial Pharmaceuticals has entered into a new Purchase Agreement with Alumni Capi...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/adial-pharmaceuticals-new-purchase-agreement-with-alumni-capital?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/adial-pharmaceuticals-new-purchase-agreement-with-alumni-capital?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4007","ADIL"],"gpt_icon":0},{"id":"2492215064","title":"BRIEF-Adial Pharmaceuticals Inc - On Dec 13, Enters Purchase Agreement With Alumni Capital","url":"https://stock-news.laohu8.com/highlight/detail?id=2492215064","media":"Reuters","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2492215064?lang=en_us&edition=fundamental","pubTime":"2024-12-19 06:04","pubTimestamp":1734559445,"startTime":"0","endTime":"0","summary":"BRIEF-Adial Pharmaceuticals Inc - On Dec 13, Enters Purchase Agreement With Alumni CapitalDec 18  - Adial Pharmaceuticals Inc ADIL.O:ADIAL PHARMACEUTICALS INC - ON DEC 13, ENTERS PURCHASE AGREEMENT WITH ALUMNI CAPITALADIAL PHARMACEUTICALS INC - CAN SELL UP TO $10 MILLION IN SHARESSource text: [ID:n0001213900-24-110191]Further company coverage: ADIL.O ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20241218:nFWN3NJ0J8:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","ADIL"],"gpt_icon":0},{"id":"2492503211","title":"Adial Pharmaceuticals Inc - on Dec 13, Enters Purchase Agreement With Alumni Capital","url":"https://stock-news.laohu8.com/highlight/detail?id=2492503211","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2492503211?lang=en_us&edition=fundamental","pubTime":"2024-12-19 06:02","pubTimestamp":1734559324,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20241218:nFWN3NJ0J8:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["ADIL","BK4007"],"gpt_icon":0},{"id":"2492315037","title":"Adial Pharmaceuticals Inc - Can Sell up to $10 Million in Shares","url":"https://stock-news.laohu8.com/highlight/detail?id=2492315037","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2492315037?lang=en_us&edition=fundamental","pubTime":"2024-12-19 06:02","pubTimestamp":1734559324,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20241218:nFWN3NJ0J8:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["ADIL","BK4007"],"gpt_icon":0},{"id":"2489267720","title":"Adial Pharmaceuticals Extends CEO Cary Claiborne’s Tenure","url":"https://stock-news.laohu8.com/highlight/detail?id=2489267720","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2489267720?lang=en_us&edition=fundamental","pubTime":"2024-12-07 06:30","pubTimestamp":1733524226,"startTime":"0","endTime":"0","summary":"Adial Pharmaceuticals ( ($ADIL) ) has shared an announcement. Adial Pharmaceuticals has extended its CEO Cary Claiborne’s tenure with a new three-y...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/adial-pharmaceuticals-extends-ceo-cary-claibornes-tenure?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/adial-pharmaceuticals-extends-ceo-cary-claibornes-tenure?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4007","ADIL"],"gpt_icon":0},{"id":"2488917051","title":"Adial granted U.S. patent for treatment of alcohol, drug dependence","url":"https://stock-news.laohu8.com/highlight/detail?id=2488917051","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2488917051?lang=en_us&edition=fundamental","pubTime":"2024-12-03 21:35","pubTimestamp":1733232917,"startTime":"0","endTime":"0","summary":"Adial Pharmaceuticals (ADIL) announced patent number 12150931 was issued on November 26, 2024 by the United States Patent and Trademark Office, exp...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/adial-granted-u-s-patent-for-treatment-of-alcohol-drug-dependence?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/adial-granted-u-s-patent-for-treatment-of-alcohol-drug-dependence?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["ADIL","BK4007"],"gpt_icon":0},{"id":"2488917507","title":"Adial Pharmaceuticals Granted Key U.S. Patent for the Treatment of Alcohol and Drug Dependence Based on Expanded Genotype Combinations","url":"https://stock-news.laohu8.com/highlight/detail?id=2488917507","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2488917507?lang=en_us&edition=fundamental","pubTime":"2024-12-03 21:30","pubTimestamp":1733232601,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20241203:nTUA8HLBRK:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["ADIL","BK4007"],"gpt_icon":0},{"id":"2488788917","title":"Adial Pharmaceuticals Granted Key U.S. Patent for the Treatment of Alcohol and Drug Dependence Based on Expanded Genotype Combinations","url":"https://stock-news.laohu8.com/highlight/detail?id=2488788917","media":"GlobeNewswire","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2488788917?lang=en_us&edition=fundamental","pubTime":"2024-12-03 21:30","pubTimestamp":1733232600,"startTime":"0","endTime":"0","summary":"GLEN ALLEN, Va., Dec.  03, 2024  (GLOBE NEWSWIRE) -- Adial Pharmaceuticals, Inc. (NASDAQ: ADIL) (“Adial” or the “Company”), a clinical-stage biopharmaceutical company focused on developing therapies f","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2024/12/03/2990626/26135/en/Adial-Pharmaceuticals-Granted-Key-U-S-Patent-for-the-Treatment-of-Alcohol-and-Drug-Dependence-Based-on-Expanded-Genotype-Combinations.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0994945656.USD","BK4125","ADIL","WRD","LU0345774631.USD","LU0426412945.USD","AUD","BK4007","LU2238339852.HKD","LU1043141123.HKD","LU0426417589.USD"],"gpt_icon":0},{"id":"2488912706","title":"EXCLUSIVE: Adial Pharmaceuticals' Lead Drug Secures Key US Patent For  Alcohol Dependence Based on Expanded Genotype Combinations","url":"https://stock-news.laohu8.com/highlight/detail?id=2488912706","media":"Benzinga","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2488912706?lang=en_us&edition=fundamental","pubTime":"2024-12-03 21:00","pubTimestamp":1733230822,"startTime":"0","endTime":"0","summary":"On Tuesday, Adial Pharmaceuticals, Inc.  announced that patent number 12150931 was issued by the United States Patent and Trademark Office on November 26, expanding the company's intellectual property coverage.The patent covers a broader range of genotype combinations identified by the company's proprietary genetic diagnostic for targeted treatment of alcohol use disorder  with AD04, the company's lead investigational new drug product.Also Read: EXCLUSIVE: Adial Pharmaceuticals Advances Regulatory Strategy For Companion Diagnostic Genetic Test For Its Lead Program For Alcohol Use Disorder. These genotype combinations include the HTR3A, HTR3B, and SLC6A4 receptor sites, which are expected to play an important role in the company's precision medicine approach to treating addiction and may support the expansion of its pipeline.\"This patent significantly enhances our intellectual property portfolio, providing us with greater flexibility and protection as we advance AD04 toward commercializ","market":"us","thumbnail":"https://s.yimg.com/uu/api/res/1.2/aCp71ztxJyBgoAyPiWsl1g--~B/aD01NTM7dz05ODM7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/Benzinga/a7cd9edcf00b2bfab19e893fd54e37b9","type":0,"news_type":0,"thumbnails":["https://s.yimg.com/uu/api/res/1.2/aCp71ztxJyBgoAyPiWsl1g--~B/aD01NTM7dz05ODM7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/Benzinga/a7cd9edcf00b2bfab19e893fd54e37b9"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/exclusive-adial-pharmaceuticals-lead-drug-130022911.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["LU0994945656.USD","BK4218","BK4007","LU1043141123.HKD","LU0426417589.USD","BK4125","LU0426412945.USD","BK4181","LU0345774631.USD","AUD","PK","LU2238339852.HKD","ADIL"],"gpt_icon":0},{"id":"2486398056","title":"Adial Pharmaceuticals (ADIL) Upgraded to Buy: Here's What You Should Know","url":"https://stock-news.laohu8.com/highlight/detail?id=2486398056","media":"Zacks","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2486398056?lang=en_us&edition=fundamental","pubTime":"2024-11-26 01:00","pubTimestamp":1732554011,"startTime":"0","endTime":"0","summary":"Adial Pharmaceuticals, Inc.  could be a solid choice for investors given its recent upgrade to a Zacks Rank #2 . This upgrade primarily reflects an upward trend in earnings estimates, which is one of the most powerful forces impacting stock prices.The sole determinant of the Zacks rating is a company's changing earnings picture. The Zacks Consensus Estimate -- the consensus of EPS estimates from the sell-side analysts covering the stock -- for the current and following years is tracked by the system.Since a changing earnings picture is a powerful factor influencing near-term stock price movements, the Zacks rating system is very useful for individual investors. They may find it difficult to make decisions based on rating upgrades by Wall Street analysts, as these are mostly driven by subjective factors that are hard to see and measure in real time.As such, the Zacks rating upgrade for Adial Pharmaceuticals is essentially a positive comment on its earnings outlook that could have a favo","market":"us","thumbnail":"https://s.yimg.com/uu/api/res/1.2/ZVGBNd2_.kAicju5mLde7g--~B/aD02MDA7dz05MDA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/71afbbc0512eb3c471136d93f39079c9","type":0,"news_type":0,"thumbnails":["https://s.yimg.com/uu/api/res/1.2/ZVGBNd2_.kAicju5mLde7g--~B/aD02MDA7dz05MDA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/71afbbc0512eb3c471136d93f39079c9"],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/adial-pharmaceuticals-adil-upgraded-buy-170011348.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["ADIL"],"gpt_icon":0},{"id":"2484298437","title":"Adial Pharmaceuticals Advances AD04 with Promising Study Results","url":"https://stock-news.laohu8.com/highlight/detail?id=2484298437","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2484298437?lang=en_us&edition=fundamental","pubTime":"2024-11-19 05:37","pubTimestamp":1731965826,"startTime":"0","endTime":"0","summary":"Adial Pharmaceuticals ( ($ADIL) ) just unveiled an announcement. Adial Pharmaceuticals has completed a significant pharmacokinetics study for its l...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/adial-pharmaceuticals-advances-ad04-with-promising-study-results?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/adial-pharmaceuticals-advances-ad04-with-promising-study-results?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4007","ADIL"],"gpt_icon":0},{"id":"2483580375","title":"Maxim Group Sticks to Their Hold Rating for Adial Pharmaceuticals (ADIL)","url":"https://stock-news.laohu8.com/highlight/detail?id=2483580375","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2483580375?lang=en_us&edition=fundamental","pubTime":"2024-11-16 04:35","pubTimestamp":1731702912,"startTime":"0","endTime":"0","summary":"In a report released yesterday, Jason McCarthy from Maxim Group maintained a Hold rating on Adial Pharmaceuticals (ADIL – Research Report). The com...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/maxim-group-sticks-to-their-hold-rating-for-adial-pharmaceuticals-adil?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/maxim-group-sticks-to-their-hold-rating-for-adial-pharmaceuticals-adil?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["ADIL"],"gpt_icon":0},{"id":"2483385495","title":"BUZZ-U.S. STOCKS ON THE MOVE-Oklo, Adial Pharma, Sonos","url":"https://stock-news.laohu8.com/highlight/detail?id=2483385495","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2483385495?lang=en_us&edition=fundamental","pubTime":"2024-11-15 00:17","pubTimestamp":1731601060,"startTime":"0","endTime":"0","summary":"BUZZ-U.S. STOCKS ON THE MOVE-Oklo, Adial Pharma, SonosEikon search string for individual stock moves: STXBZThe Day Ahead newsletter: https://refini.tv/3LI4BU7The Morning News Call newsletter: https://","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20241114:nL4N3ML1CS:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["AMGN","BW","3NVD.UK","AAL","NVD2.UK","SONO","GWH","CSCO","NVDD","LU2237443549.SGD","SNVD.UK","HLT","NVDS.UK","NVDU","OKLO","NVD3.UK","DOCS","HROW","DIS","HUT","NEM","NVDL","NVDY","PZZA","RIOT","ADIL","LU0154245673.USD","NVDS","NVDX","2NVD.UK","ALSN","PTCT","NVD","NVDA","VTR","MA","CPB","LU0082616367.USD","MARA","AAP","ZETA","ACIU","CNH","LU0724617625.USD","AESI","HIMS","COIN","MRK","TPR"],"gpt_icon":1},{"id":"2483801371","title":"Adial Pharmaceuticals Shares up 18% on Data for Alcohol Abuse Drug","url":"https://stock-news.laohu8.com/highlight/detail?id=2483801371","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2483801371?lang=en_us&edition=fundamental","pubTime":"2024-11-14 22:34","pubTimestamp":1731594843,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20241114:nFWN3ML16W:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4007","ADIL"],"gpt_icon":0},{"id":"2483062578","title":"Adial Pharmaceuticals Inc reports results for the quarter ended September 30 - Earnings Summary","url":"https://stock-news.laohu8.com/highlight/detail?id=2483062578","media":"Reuters","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2483062578?lang=en_us&edition=fundamental","pubTime":"2024-11-14 22:16","pubTimestamp":1731593803,"startTime":"0","endTime":"0","summary":"* Adial Pharmaceuticals Inc    reported a quarterly adjusted loss of 38 cents per share for the quarter ended September 30, higher than the same quarter last year, when the company reported EPS of $-1","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":"Adial Pharmaceuticals Inc reports results for the quarter ended September 30 - Earnings Summary","news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ADIL"],"gpt_icon":0},{"id":"2483805772","title":"BUZZ-Adial Pharma jumps on data for alcohol abuse drug","url":"https://stock-news.laohu8.com/highlight/detail?id=2483805772","media":"Reuters","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2483805772?lang=en_us&edition=fundamental","pubTime":"2024-11-14 22:03","pubTimestamp":1731593002,"startTime":"0","endTime":"0","summary":"** Shares of drug developer Adial Pharmaceuticals    rise 12% to $1.11 premarket    ** Co says AD04, its lead drug candidate being developed to treat alcohol-use disorder in heavy-drinking patients, showed safety and tolerability consistent with an existing treatment   ** Study enrolled 30 healthy adult volunteers, ADIL says   ** Says completion of the study satisfied an FDA requirement for the upcoming late-stage trials of the oral drug   ** Co plans to meet with FDA in Q4 2024 with the results of the study   ** Up to last close, stock down ~47% YTD  ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","ADIL"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.adialpharma.com","stockEarnings":[{"period":"1week","weight":0.0686},{"period":"1month","weight":-0.084},{"period":"3month","weight":0.1224},{"period":"6month","weight":0.041},{"period":"1year","weight":-0.3663},{"period":"ytd","weight":0.0792}],"compareEarnings":[{"period":"1week","weight":-0.0051},{"period":"1month","weight":-0.0259},{"period":"3month","weight":0.0331},{"period":"6month","weight":0.0673},{"period":"1year","weight":0.2668},{"period":"ytd","weight":0.01}],"compareStock":{"symbol":"SPY","name":"SPDR S&P 500 ETF Trust"},"description":"Adial Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on the development of therapeutics for the treatment or prevention of addiction and related disorders. The company's lead product is AD04, a serotonin-3 antagonist, which is in Phase 3 clinical trials for the treatment of alcohol use disorder. It is also involved in the development of drug candidates for non-opioid pain reduction and other diseases and disorders. The company was founded in 2010 and is based in Glen Allen, Virginia.","yearOnYearQuotes":[{"month":1,"riseRate":0.571429,"avgChangeRate":0.108584},{"month":2,"riseRate":0.333333,"avgChangeRate":0.054105},{"month":3,"riseRate":0,"avgChangeRate":-0.126633},{"month":4,"riseRate":0.333333,"avgChangeRate":-0.03704},{"month":5,"riseRate":0.333333,"avgChangeRate":-0.095363},{"month":6,"riseRate":0.333333,"avgChangeRate":-0.091774},{"month":7,"riseRate":0.5,"avgChangeRate":0.019629},{"month":8,"riseRate":0.142857,"avgChangeRate":-0.065704},{"month":9,"riseRate":0.428571,"avgChangeRate":-0.033423},{"month":10,"riseRate":0.285714,"avgChangeRate":-0.173095},{"month":11,"riseRate":0.428571,"avgChangeRate":0.173895},{"month":12,"riseRate":0.428571,"avgChangeRate":0.050306}],"exchange":"NASDAQ","name":"Adial Pharmaceuticals","nameEN":"Adial Pharmaceuticals"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"deviceId":"web-server-community-laohu8-v3","version":"4.29.4","shortVersion":"4.29.4","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Adial Pharmaceuticals(ADIL),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","description":"Find the latest Adial Pharmaceuticals(ADIL) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","keywords":"Adial Pharmaceuticals,ADIL,Adial Pharmaceuticals股票,Adial Pharmaceuticals股票老虎,Adial Pharmaceuticals股票老虎国际,Adial Pharmaceuticals行情,Adial Pharmaceuticals股票行情,Adial Pharmaceuticals股价,Adial Pharmaceuticals股市,Adial Pharmaceuticals股票价格,Adial Pharmaceuticals股票交易,Adial Pharmaceuticals股票购买,Adial Pharmaceuticals股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Adial Pharmaceuticals(ADIL),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","og_description":"Find the latest Adial Pharmaceuticals(ADIL) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","og_image":"https://community-static.tradeup.com/news/9b6dafd60190235ae8e2c95f52c583a0"}}}